`
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`______________
`
`
`APPLE INC.,
`Petitioner,
`
`v.
`
`OMNI MEDSCI, INC.,
`Patent Owner.
`
`______________
`
`
`U.S. Patent No. 10,188,299
`
`IPR Case No.: IPR2020-00175
`
`
`______________
`
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICE
`
`
`
`
`
`
`
`Case No.: IPR2020-00175
`Patent No.: 10,188,299
`
`
`I. Mandatory Notices under 37 C.F.R. § 42.8
`
`Atty. Dkt. No.: OMSC0117IPR1
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, Omni MedSci, Inc. (“Patent
`
`Owner”), submits the following Mandatory Notices in response to the Petition for
`
`Inter Partes Review of U.S. Patent No. 10,188,299 (“the ‘299 Patent”).
`
`
`
`A. Real Party-In-Interest - 37 C.F.R. § 42.8(b)(1)
`
`Patent Owner certifies that Omni MedSci, Inc. is the real party-in-interest in
`
`this proceeding.
`
`
`
`B. Related Matters - 37 C.F.R. § 42.8(b)(2)
`
`1.
`
`Patents and Applications
`
`The ‘299 Patent is related to the following issued patents or pending
`
`applications:
`
`• U.S. Patent No. 9,651,533 (“the ’533 patent”)
`
`• U.S. Patent No. 9,164,032
`
`2.
`
`Related Litigation
`
`The ‘299 Patent has been asserted in the following litigations:
`
`• Omni MedSci, Inc. v. Apple Inc., Action No. 2-19-cv-05673-
`
`YGR (N.D. Cal.) (pending); and
`
`1
`
`
`
`Case No.: IPR2020-00175
`Patent No.: 10,188,299
`
`
`
`Atty. Dkt. No.: OMSC0117IPR1
`
`• Omni MedSci, Inc. v. Apple Inc., Action No. 2-18-cv-00429-
`
`RWS (E.D. Tex.) (transferred to N.D. Cal.).
`
`The ‘533 patent has been asserted in the following litigations:
`
`• Omni MedSci, Inc. v. Apple Inc., Action No. 2-19-cv-05924
`
`(N.D. Cal.) (pending); and
`
`• Omni MedSci, Inc. v. Apple Inc., Action No. 2-18-cv-00134-
`
`RWS (E.D. Tex.) (transferred to N.D. Cal.).
`
`3.
`
`Patent Office Proceedings
`
`The ’299 Patent is not subject to any other proceedings before the Office. The
`
`’299 Patent’s parent, the ’533 patent, is subject to IPR2019-00913 (terminated) and
`
`IPR2019-00916 (instituted, pending), filed by Apple.
`
`
`
`C. Lead and Back-Up Counsel - 37 C.F.R. § 42.8(b)(3)
`
`The Patent Owner identifies the following lead and back-up counsel:
`
`
`
`Lead Counsel
`Thomas A. Lewry (Reg. No. 30,770)
`BROOKS KUSHMAN P.C.
`1000 Town Center, 22nd Floor
`Southfield, MI 48075
`Telephone (248) 358-4400
`Facsimile (248) 358-3351
`
`
`
`2
`
`
`
`Case No.: IPR2020-00175
`Patent No.: 10,188,299
`
`
`
`Atty. Dkt. No.: OMSC0117IPR1
`
`First Back-Up Counsel
`John S. LeRoy (Reg. No. 48,158)
`BROOKS KUSHMAN P.C.
`1000 Town Center, 22nd Floor
`Southfield, MI 48075
`Telephone (248) 358-4400
`Facsimile (248) 358-3351
`Back-Up Counsel
`Robert C. J. Tuttle (Reg. No. 27,962)
`John M. Halan (Reg. No. 35,534)
`Christopher C. Smith (Reg. No. 59,669)
`Andrew B. Turner (Reg. No. 63,121)
`BROOKS KUSHMAN P.C.
`1000 Town Center, 22nd Floor
`Southfield, Michigan 48075
`Telephone (248) 358-4400
`Facsimile (248) 358-3351
`
`
`Pursuant to 37 C.F.R. § 42.10(b), an appropriate Power of Attorney is filed
`
`concurrently.
`
`D.
`
`Service Information - 37 C.F.R. § 42.8(b)(4)
`
`Service information for lead and back-up counsel is provided in the
`
`designation of lead and back-up counsel above. Patent Owner consents to service by
`
`email at the following email address: OMSC0117IPR1@brookskushman.com.
`
`
`
`
`
`
`
`Dated: Janury 2, 2020
`
`
`
`Respectfully submitted,
`
`
`
` /Thomas A. Lewry/
`Thomas A. Lewry (Reg. No. 30,770)
`John S. LeRoy (Reg. No. 48,158)
`Robert C. J. Tuttle (Reg. No. 27,962)
`John M. Halan (Reg. No. 35,534)
`
`3
`
`
`
`Case No.: IPR2020-00175
`Patent No.: 10,188,299
`
`
`
`
`
`
`
`Atty. Dkt. No.: OMSC0117IPR1
`
`Christopher C. Smith (Reg. No. 59,669)
`Andrew B. Turner (Reg. No. 63,121)
`BROOKS KUSHMAN P.C.
`1000 Town Center, Twenty-Second Floor
`Southfield, Michigan 48075
`Telephone: (248) 358-4400
`
`Attorneys for Omni MedSci, Inc.
`
`
`4
`
`
`
`Case No.: IPR2020-00175
`Patent No.: 10,188,299
`
`
`
`Atty. Dkt. No.: OMSC0117IPR1
`
`Certificate of Service
`
`The undersigned hereby certifies that on January 2, 2020, a complete and
`entire copy of Patent Owner’s Mandatory Notice, was served via electronic mail
`by serving the correspondence email address of IPRnotices@sidley.com, which
`delivers to the following lead and back-up counsel:
`
`
`LEAD COUNSEL
`Jeffrey P. Kushan (Reg. No.
`43,401)
`SIDLEY AUSTIN LLP
`1501 K Street NW
`Washington, DC 20005
`(202) 736-8914
`
`BACK-UP COUNSEL
`Ching-Lee Fukuda (Reg. No. 44,334)
`Sidley Austin LLP
`787 Seventh Avenue
`New York, NY 10019
`(212) 839-7364
`
`Thomas A. Broughan III (Reg. No. 66,001)
`Kathi Cover (Reg. No. 37,803)
`Sidley Austin LLP
`1501 K Street NW
`Washington, DC 20005
`(202) 736-8314
`
`Sharon Lee (pro hac vice to be submitted)
`sharon.lee@sidley.com, (212) 839-7305
`
`Respectfully submitted,
`
`
` /Thomas A. Lewry/
`Thomas A. Lewry (Reg. No. 30,770)
`John S. LeRoy (Reg. No. 48,158)
`Robert C. J. Tuttle (Reg. No. 27,962)
`John M. Halan (Reg. No. 35,534)
`Christopher C. Smith (Reg. No. 59,669)
`Andrew B. Turner (Reg. No. 63,121)
`BROOKS KUSHMAN P.C.
`1000 Town Center, Twenty-Second Floor
`Southfield, Michigan 48075
`Telephone: (248) 358-4400
`
`Attorneys for Omni MedSci, Inc.
`
`5
`
`